Feasibility of using machine learning on insurance claims to identify correlates of lower extremity amputation in insured adults with type 2 diabetes who initiate treatment with sodium-glucose co-transporter 2 (SGLT-2) inhibitors.
Feasibility of using machine learning on insurance claims to identify correlates of lower extremity amputation in insured adults with type 2 diabetes who initiate treatment with sodium-glucose co-transporter 2 (SGLT-2) inhibitors.
(xsd:string)
Feasibility of using machine learning on insurance claims to identify correlates of lower extremity amputation in insured adults with type 2 diabetes who initiate treatment with sodium-glucose co-transporter 2 (SGLT-2) inhibitors.
(xsd:string)